Clinical trials market

Read our disclaimer for details. Before participating in a study, talk to your health care provider and learn about the risks and potential benefits. Learn more. Try the modernized ClinicalTrials. Learn more about the modernization effort. Hide glossary Glossary Study record managers: refer to the Data Element Definitions if submitting registration or results information. Search for terms. Regionally, clinical trials market is dominated by North America due to high incidence of chronic disorders and presence of latest healthcare infrastructure.

On the other hand, Asia-Pacific is anticipated to witness the rapid growth rate, on account of increasing investment by governments in research and growing awareness regarding precision medicine.

The companies focusing on research and development are expected to lead the global clinical trials market. Leading competitors contending in global clinical trials market are as follows:. In order to better recognize the current status of clinical trials, and policies adopted by the foremost countries, Precedence Research predicted the future evolution of the clinical trials market. This research study bids qualitative and quantitative insights on clinical trials market and assessment of market size and growth trend for potential market segments.

No cookie-cutter, only authentic analysis — take the 1st step to become an Precedence Research client. Please enter your business email. Frequently Asked Questions What is the current size of the global clinical trials market? Precedence Research announced, the global clinical trials market size was valued at USD What is the growth rate of clinical trials market? The global clinical trials market is growing at a impressive CAGR of 5.

Which factors driving the growth of the clinical trials market? Factors such as growing prevalence of chronic disorders, increasing number of clinical trials in developing regions, growing number of biologics, increasing demand for advanced treatments such as personalized medicines, outbreak of viral diseases, increasing cases of cancer globally, growing geriatric population and growing research and development expenditure are propelling the clinical trials market expansion across the globe.

Which major companies are operating in the worldwide clinical trials market? It is highly likely that pilot projects and investments to validate digital measures will continue to rise, abreast the uptake of patient centricity to empower convenient and personalized approaches. Pzifer has already started focusing on new launches of web-based clinical trial outreach platforms, and other companies followed suit.

Such efforts mark a new milestone for the global clinical trials space and fine tune the way clinical trials were conducted. These regions often gain the first mover advantage in almost every technological disruption in light of their economic vigor; and in case of clinical trials, pharmaceutical giants are adopting artificial intelligence to disrupt all stages of the process — from linking eligible patients to respective studies, to monitoring data collection and adherence.

The clinical trials landscape is witnessing a revolutionary phase, where new sources of data are being generated and put in the hands of patients. Pharma and medical device companies are emphasizing to bridge the gap between current scope of patient access at present and future, to help them maintain a healthy lifestyle. High focus is also being placed on adaptive trial designs, which eases mid-study modifications based on accumulated data.

Faster clinical trials are crucial for pharma and medical device companies, as these are time- and capital-intensive. Spending on phase III clinical trials remains comparatively higher than phase II and phase I trials, owing to their greater complexity and need for larger patient pool.

Sponsors are highly likely to see greater room for success in developing regions, such as South Asia and East Asia. Moreover, the conduction of clinical trials across this fast-growing regions promises a new shade of advantages, including tax incentives and efficient regulatory pathways.

Your personal details are safe with us. Read More I Agree. Request Sample Schedule a Call. Need immediate assistance? Home Report Clinical Trials Market.